Synthesis and anticancer activities of 6-amino amonafide derivatives

@article{Norton2008SynthesisAA,
  title={Synthesis and anticancer activities of 6-amino amonafide derivatives},
  author={John T Norton and Mark A. Witschi and L. Luong and A. Kawamura and S. Ghosh and M. Sharon Stack and E. Sim and M. Avram and D. Appella and S. Huang},
  journal={Anti-Cancer Drugs},
  year={2008},
  volume={19},
  pages={23-36}
}
  • John T Norton, Mark A. Witschi, +7 authors S. Huang
  • Published 2008
  • Chemistry, Medicine
  • Anti-Cancer Drugs
    • Amonafide is a DNA intercalator and topoisomerase II inhibitor in clinical development for the treatment of neoplastic diseases. Amonafide contains a free arylamine, which causes it to be metabolized in humans by N-acetyl transferase-2 (NAT2) into a toxic form. To eliminate the NAT2 acetylation of amonafide while retaining the anticancer properties, we have synthesized nine derivatives that are structurally similar to amonafide that should not be acetylated. Eight derivatives have arylamines at… CONTINUE READING
    View on Wolters Kluwer
    ncbi.nlm.nih.gov
    38 Citations
    Highly Influencial Citations
    1
    Background Citations
    9
    Methods Citations
    2
    Results Citations
    2
    38 Citations
    Citation Type

    Citation Type

    Synthesis, cytotoxicity, DNA binding and topoisomerase II inhibition of cassiarin A derivatives.
    • 9
    Is an Efficacious and Minimally Toxic Amonafide Derivative in Murine Models of Human Cancer 1
    Synthesis and evaluation of novel amonafide–polyamine conjugates as anticancer agents
    • 5
    Anticancer Activity and Topoisomerase II Inhibition of Naphthalimides with ω-Hydroxylalkylamine Side-Chains of Different Lengths.
    Evaluation of apoptotic effect of cyclic imide derivatives on murine B16F10 melanoma cells.
    • 21
    Methoxyethylamino-numonafide is an efficacious and minimally toxic amonafide derivative in murine models of human cancer.
    • 15
    • PDF
    Induction of apoptosis and suppression of ERCC1 expression by the potent amonafide analogue 8-c in human colorectal carcinoma cells
    • 5
    Novel naphthalimide derivatives as potential apoptosis-inducing agents: design, synthesis and biological evaluation.
    • 31
    Synthesis, anticancer activity and DNA-binding properties of novel 4-pyrazolyl-1,8-naphthalimide derivatives.
    • 26
    Naphthalimides and analogues as antitumor agents: A review on molecular design, bioactivity and mechanism of action
    • 12

    References

    SHOWING 1-10 OF 30 REFERENCES
    Pharmacogenetics of anticancer agents: lessons from amonafide and irinotecan.
    • 89
    • PDF
    Eukaryotic arylamine N-acetyltransferase. Investigation of substrate specificity by high-throughput screening.
    • 94
    New analogues of amonafide and elinafide, containing aromatic heterocycles: synthesis, antitumor activity, molecular modeling, and DNA binding properties.
    • 97
    Pharmacokinetics and metabolism of the antitumor drug amonafide (NSC-308847) in humans.
    • 34
    In vitro toxicity and DNA cleaving capacity of benzisoquinolinedione (nafidimide; NSC 308847) in human leukemia.
    • 33
    Topoisomerase II-mediated DNA cleavage by amonafide and its structural analogs.
    • 89
    In vitro cytotoxicity and DNA damage production in Chinese hamster ovary cells and topoisomerase II inhibition by 2-[2'- (dimethylamino)ethyl]-1,2-dihydro-3H-dibenz[ de,h]isoquinoline-1,3-diones with substitutions at the 6 and 7 positions (azonafides)
    • 13
    Base sequence determinants of amonafide stimulation of topoisomerase II DNA cleavage.
    • 33
    Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642).
    • M. Costanza, D. Berry, +7 authors A. Lyss
    • Medicine
    • Clinical cancer research : an official journal of the American Association for Cancer Research
    • 1995
    • 41
    • PDF
    ATP-bound Topoisomerase II as a Target for Antitumor Drugs*
    • 53
    • PDF